Molecular interactions between (-)-epigallocatechin gallate analogs and pancreatic lipase

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Wang, Shihui ^a   Sun, Zeya ^a   Dong, Shengzhao ^a   Liu, Yang ^a   Liu, Yun ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN GALLATE; OLIVE OIL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; CATECHIN; PANCRELIPASE; PROTEIN BINDING;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SUBSTRATE; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HYDRODYNAMICS; IN VITRO STUDY; LIGHT SCATTERING; MOLECULAR INTERACTION; PROTEIN ASSEMBLY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; THERMOSTABILITY; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; KINETICS; METABOLISM; PIG; THERMODYNAMICS;

ANIMALS; CATECHIN; ENZYME ACTIVATION; HYDRODYNAMICS; KINETICS; MOLECULAR STRUCTURE; PANCRELIPASE; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SWINE; THERMODYNAMICS;

EID: 84909592370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111143     Document Type: Article

References (40)

1. Lean M, Lara J, Hill JO (2006) ABC of obesity: Strategies for preventing obesity. BMJ: British Medical Journal 333: 959.
2. Puhl RM, Heuer CA (2009) The Stigma of Obesity: A Review and Update. Obesity 17: 941-964.
3. Wang Z, Li S, Sun L, Fan J, Liu Z (2013) Comparative analyses of lipoprotein lipase, hepatic lipase, and endothelial lipase, and their binding properties with known inhibitors. PloS one 8: e72146.
4. Mendes AA, Oliveira PC, de Castro HF (2012) Properties and biotechnological applications of porcine pancreatic lipase. J Mol Catal B: Enzym 78: 119-134.
5. Cai S, Wang O, Wang M, He J, Wang Y, et al. (2012) In vitro inhibitory effect on pancreatic lipase activity of subfractions from ethanol extracts of fermented oats (Avena sativa L.) and synergistic effect of three phenolic acids. J Agr Food Chem 60: 7245-7251.
6. Lowe M (1994) Pancreatic triglyceride lipase and colipase: insights into dietary fat digestion. Gastroenterology 107: 1524-1524.
7. Ballinger A, Peikin SR (2002) Orlistat: its current status as an anti-obesity drug. Eur J Pharmacol 440: 109-117.
8. de la Garza AL, Milagro FI, Boque N, Campión J, Martnez JA (2011) Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Med 77: 773-785.
9. Zhou J, Farah BL, Sinha RA, Wu Y, Singh BK, et al. (2014) Epigallocatechin-3-Gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PloS one 9: e87161.
10. Chen L, Ye H-L, Zhang G, Yao W-M, Chen X-Z, et al. (2014) Autophagy Inhibition Contributes to the Synergistic Interaction between EGCG and Doxorubicin to Kill the Hepatoma Hep3B Cells. PloS one 9: e85771.
11. Wolfram S, Wang Y, Thielecke F (2006) Anti-obesity effects of green tea: From bedside to bench. Mol Nutr Food Res 50: 176-187.
12. de Mejia EG, Ramirez-Mares MV, Puangpraphant S (2009) Bioactive components of tea: cancer, inflammation and behavior. Brain, behavior, and immunity 23: 721-731.
13. Tang S-N, Fu J, Shankar S, Srivastava RK (2012) EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PloS one 7: e31067.
14. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, et al. (2008) The major green tea polyphenol,(-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138: 1677-1683.
15. Sergent T, Vanderstraeten J, Winand J, Beguin P, Schneider Y-J (2012) Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem 135: 68-73.
16. Grove KA, Sae-tan S, Kennett MJ, Lambert JD (2012) (-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity 20: 2311-2313.
17. Nakai M, Fukui Y, Asami S, Toyoda-Ono Y, Iwashita T, et al. (2005) Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agr Food Chem 53: 4593-4598.
18. Liu Y, Chen D, Xu L, Yan Y (2012) Evaluation of structure and hydrolysis activity of Candida rugosa Lip7 in presence of sub-/super-critical CO2. Enzyme Microb Technol 51: 354-358.
19. Wang S, Dong S, Zhang R, Shao H, Liu Y (2014) Effects of proanthocyanidins on porcine pancreatic lipase: conformation, activity, kinetics and thermodynamics. Process Biochem 49: 237-243.
20. DichroWeb. Available: http://dichroweb.cryst.bbk.ac.uk/html/home.shtml Accessed 2014 April 5.
21. Wang S-H, Liu F-F, Dong X-Y, Sun Y (2012) Calorimetric and spectroscopic studies of the interactions between insulin and (-)-epigallocatechin-3-gallate. Biochem Eng J 62: 70-78.
22. Gonccalves R, Mateus N, de Freitas V (2010) Study of the interaction of pancreatic lipase with procyanidins by optical and enzymatic methods. J Agr Food Chem 58: 11901-11906.
23. Ramos P, Coste T, Piémont E, Lessinger JM, Bousquet JA, et al. (2003) Timeresolved fluorescence allows selective monitoring of Trp30 environmental changes in the seven-Trp-containing human pancreatic lipase. Biochemistry 42: 12488-12496.
24. Papadopoulou A, Green RJ, Frazier RA (2005) Interaction of flavonoids with bovine serum albumin: a fluorescence quenching study. J Agr Food Chem 53: 158-163.
25. Wang S-H, Dong X-Y, Sun Y (2012) Investigation into the mechanism of (-)-epigallocatechin-3-gallate-induced precipitation of insulin. Int J Biol Macromol 50: 1229-1237.
26. Liu Y, Zhang X, Tan H, Yan Y, Hameed B (2010) Effect of pretreatment by different organic solvents on esterification activity and conformation of immobilized Pseudomonas cepacia lipase. Process Biochem 45: 1176-1180.
27. Winkler FK, D'Arcy A, Hunziker W (1990) Structure of human pancreatic lipase. Nature 343: 771-774.
28. Schrag JD, Li YG, Wu S, Cygler M (1991) Ser-His-Glu triad forms the catalytic site of the lipase from Geotrichum candidum. Nature 351: 761-764.
29. Mahapatra P, Kumari A, Kumar GV, Banerjee R, Nag A (2008) Kinetics of solvent-free geranyl acetate synthesis by Rhizopus oligosporus NRRL 5905 lipase immobilized on to cross-linked silica. Biocatal Biotransfor 27: 124-130.
30. Soares S, Mateus N, de Freitas V (2007) Interaction of different polyphenols with bovine serum albumin (BSA) and human salivary a-amylase (HSA) by fluorescence quenching. J Agr Food Chem 55: 6726-6735.
31. Skrt M, Benedik E, Podlipnik C, Ulrih NP (2012) Interactions of different polyphenols with bovine serum albumin using fluorescence quenching and molecular docking. Food Chem 135: 2418-2424.
32. Rabbani G, Ahmad E, Zaidi N, Fatima S, Khan RH (2012) pH-Induced Molten Globule State of Rhizopus niveus Lipase is More Resistant Against Thermal and Chemical Denaturation Than Its Native State. Cell Biochem Biophys 62: 487-499.
33. Wang S-H, Dong X-Y, Sun Y (2012) Effect of (-)-epigallocatechin-3-gallate on human insulin fibrillation/aggregation kinetics. Biochem Eng J 63: 38-49.
34. Wang S-H, Dong X-Y, Sun Y (2012) Thermodynamic analysis of the molecular interactions between amyloid b-protein fragments and (-)-epigallocatechin-3-gallate. J Phys Chem B 116: 5803-5809.
35. Wang S-H, Liu F-F, Dong X-Y, Sun Y (2010) Thermodynamic analysis of the molecular interactions between amyloid beta-peptide 42 and (-)-epigallocatechin-3-gallate. J Phys Chem B 114: 11576-11583.
36. Meng F, Abedini A, Plesner A, Verchere CB, Raleigh DP (2010) The flavanol (2)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 49: 8127-8133.
37. Hasni I, Bourassa P, Hamdani S, Samson G, Carpentier R, et al. (2011) Interaction of milk alpha-and beta-caseins with tea polyphenols. Food Chem 126: 630-639.
38. McGraw SE, Lindenbaum S (1990) The use of microcalorimetry to measure thermodynamic parameters of the binding of ligands to insulin. Pharmaceut Res 7: 606-611.
39. Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, et al. (2008) Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid b protein. Neurosci Lett 444: 280-285.
40. Ishii T, Ichikawa T, Minoda K, Kusaka K, Ito S, et al. (2010) Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization. Biosci Biotechn Biochem 75: 100-106.